Banco De Sabadell, S.A Pfizer Inc Transaction History

Banco De Sabadell, S.A

$133 Million
Q3 2024

A detailed history of Banco De Sabadell, S.A transactions in Pfizer Inc stock. As of the latest transaction made, Banco De Sabadell, S.A holds 76,792 shares of PFE stock, worth $2.05 Million. This represents 1.67% of its overall portfolio holdings.

Number of Shares

76,792

Previous 68,769 11.67%

Holding current value

$2.05 Million

Previous $1.93 Million 15.58%

% of portfolio

1.67%

Previous 1.41%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$27.7 - $31.39 $222,237 - $251,841	8,023 Added 11.67%	76,792 $2.23 Million
Q2 2024 Aug 13, 2024	SELL	$25.26 - $29.6 $50,494 - $59,170	-1,999 Reduced 2.82%	68,769 $1.93 Million
Q1 2024 May 13, 2024	SELL	$25.89 - $29.73 $28,271 - $32,465	-1,092 Reduced 1.52%	70,768 $1.97 Million
Q4 2023 Feb 09, 2024	BUY	$26.13 - $33.94 $910,499 - $1.18 Million	34,845 Added 94.14%	71,860 $2.06 Million
Q3 2023 Nov 13, 2023	SELL	$32.09 - $37.51 $121,428 - $141,937	-3,784 Reduced 9.27%	37,015 $1.22 Million
Q2 2023 Aug 14, 2023	SELL	$36.12 - $41.79 $50,062 - $57,920	-1,386 Reduced 3.29%	40,799 $1.5 Million
Q1 2023 May 12, 2023	SELL	$39.39 - $51.28 $100,838 - $131,276	-2,560 Reduced 5.72%	42,185 $1.72 Million
Q4 2022 Feb 14, 2023	SELL	$41.75 - $54.5 $209,418 - $273,372	-5,016 Reduced 10.08%	44,745 $2.3 Million
Q3 2022 Nov 10, 2022	BUY	$43.76 - $53.42 $27,481 - $33,547	628 Added 1.28%	49,761 $2.18 Million
Q2 2022 Aug 11, 2022	SELL	$46.53 - $55.17 $23,776 - $28,191	-511 Reduced 1.03%	49,133 $2.58 Million
Q1 2022 May 12, 2022	BUY	$45.75 - $56.69 $104,584 - $129,593	2,286 Added 4.83%	49,644 $2.57 Million
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $280,686 - $416,071	6,793 Added 16.75%	47,358 $2.8 Million
Q3 2021 Nov 04, 2021	SELL	$39.25 - $50.42 $147,854 - $189,932	-3,767 Reduced 8.5%	40,565 $1.75 Million
Q2 2021 Aug 13, 2021	SELL	$35.91 - $40.68 $10.8 Million - $12.2 Million	-299,850 Reduced 87.12%	44,332 $1.74 Million
Q1 2021 May 14, 2021	BUY	$33.49 - $37.77 $8.87 Million - $10 Million	264,713 Added 333.1%	344,182 $12.5 Million
Q4 2020 Feb 12, 2021	SELL	$33.47 - $42.56 $5.55 Million - $7.05 Million	-165,725 Reduced 67.59%	79,469 $2.93 Million
Q3 2020 Nov 13, 2020	SELL	$31.75 - $37.25 $1.89 Million - $2.22 Million	-59,474 Reduced 19.52%	245,194 $8.94 Million
Q2 2020 Aug 07, 2020	BUY	$30.12 - $36.54 $569,298 - $690,642	18,901 Added 6.61%	304,668 $9.96 Million
Q1 2020 May 14, 2020	SELL	$27.03 - $38.62 $324,927 - $464,251	-12,021 Reduced 4.04%	285,767 $9.27 Million
Q4 2019 Feb 14, 2020	SELL	$32.92 - $37.36 $602,831 - $684,136	-18,312 Reduced 5.79%	297,788 $11.6 Million
Q3 2019 Nov 15, 2019	SELL	$32.49 - $42.13 $355,505 - $460,986	-10,942 Reduced 3.35%	316,100 $11.4 Million
Q2 2019 Aug 13, 2019	BUY	$36.98 - $41.52 $10.5 Million - $11.8 Million	283,615 Added 653.08%	327,042 $14.2 Million
Q1 2019 May 14, 2019	SELL	$37.5 - $41.2 $13.1 Million - $14.3 Million	-348,288 Reduced 88.91%	43,427 $1.84 Million
Q4 2018 Feb 14, 2019	BUY	$38.47 - $43.86 $1.88 Million - $2.14 Million	48,761 Added 14.22%	391,715 $16.9 Million
Q3 2018 Nov 16, 2018	BUY	$34.47 - $41.81 $2.31 Million - $2.81 Million	67,149 Added 24.35%	342,954 $15.1 Million
Q2 2018 Aug 15, 2018	SELL	$32.98 - $35.16 $2.15 Million - $2.29 Million	-65,244 Reduced 19.13%	275,805 $10 Million
Q1 2018 May 16, 2018	BUY	$31.91 - $37.02 $573,614 - $665,471	17,976 Added 5.56%	341,049 $12 Million
Q4 2017 Feb 16, 2018	BUY	$33.26 - $35.29 $10.7 Million - $11.4 Million	323,073	323,073 $11.7 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Banco De Sabadell, S.A, based on Form 13F filings with the SEC.

News

Stay updated on Banco De Sabadell, S.A with notifications on news.

Account

Banco De Sabadell, S.A Pfizer Inc Transaction History